AbbVie Statistics
Share Statistics
AbbVie has 1.77B
shares outstanding. The number of shares has increased by 0.18%
in one year.
| Shares Outstanding | 1.77B |
| Shares Change (YoY) | 0.18% |
| Shares Change (QoQ) | 0.1% |
| Owned by Institutions (%) | 71.96% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 37,981 |
| FTD / Avg. Volume | 0.5% |
Short Selling Information
The latest short interest is 16.84M, so 0.95% of the outstanding
shares have been sold short.
| Short Interest | 16.84M |
| Short % of Shares Out | 0.95% |
| Short % of Float | 0.95% |
| Short Ratio (days to cover) | 1.54 |
Valuation Ratios
The PE ratio is 73.33 and the forward
PE ratio is 13.41.
AbbVie's PEG ratio is
-6.46.
| PE Ratio | 73.33 |
| Forward PE | 13.41 |
| PS Ratio | 5.57 |
| Forward PS | 4.3 |
| PB Ratio | 94.34 |
| P/FCF Ratio | 17.59 |
| PEG Ratio | -6.46 |
Financial Ratio HistoryEnterprise Valuation
AbbVie has an Enterprise Value (EV) of 375.31B.
| EV / Sales | 6.66 |
| EV / EBITDA | 24.93 |
| EV / EBIT | 19.96 |
| EV / FCF | 21.05 |
Financial Position
The company has a current ratio of 0.66,
with a Debt / Equity ratio of 20.19.
| Current Ratio | 0.66 |
| Quick Ratio | 0.55 |
| Debt / Equity | 20.19 |
| Debt / EBITDA | 4.46 |
| Debt / FCF | 3.77 |
| Interest Coverage | 3.25 |
Financial Efficiency
Return on Equity is 128.66% and Return on Invested Capital is 10.21%.
| Return on Equity | 128.66% |
| Return on Assets | 3.17% |
| Return on Invested Capital | 10.21% |
| Revenue Per Employee | $1,024,254.55 |
| Profits Per Employee | $77,781.82 |
| Employee Count | 55,000 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 4.04 |
Taxes
| Income Tax | -570M |
| Effective Tax Rate | -15.34% |
Stock Price Statistics
The stock price has increased by 15.71% in the
last 52 weeks. The beta is 0.55, so AbbVie's
price volatility has been higher than the market average.
| Beta | 0.55 |
| 52-Week Price Change | 15.71% |
| 50-Day Moving Average | 196.73 |
| 200-Day Moving Average | 189.22 |
| Relative Strength Index (RSI) | 46.08 |
| Average Volume (20 Days) | 7,624,647 |
Income Statement
In the last 12 months, AbbVie had revenue of 56.33B
and earned 4.28B
in profits. Earnings per share was 2.42.
| Revenue | 56.33B |
| Gross Profit | 39.43B |
| Operating Income | 9.14B |
| Net Income | 4.28B |
| EBITDA | 15.06B |
| EBIT | 6.52B |
| Earnings Per Share (EPS) | 2.42 |
Full Income StatementBalance Sheet
The company has 5.52B in cash and 67.14B in
debt, giving a net cash position of -61.62B.
| Cash & Cash Equivalents | 5.52B |
| Total Debt | 67.14B |
| Net Cash | -61.62B |
| Retained Earnings | -7.9B |
| Total Assets | 135.16B |
| Working Capital | -13.17B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 18.81B
and capital expenditures 0, giving a free cash flow of 17.83B.
| Operating Cash Flow | 18.81B |
| Capital Expenditures | n/a |
| Free Cash Flow | 17.83B |
| FCF Per Share | 10.1 |
Full Cash Flow StatementMargins
Gross margin is 69.99%, with operating and profit margins of 16.22% and 7.59%.
| Gross Margin | 69.99% |
| Operating Margin | 16.22% |
| Pretax Margin | 6.6% |
| Profit Margin | 7.59% |
| EBITDA Margin | 26.73% |
| EBIT Margin | 16.22% |
| FCF Margin | 31.65% |
